Ready to invest?
Open a free brokerage account and start building your portfolio today.
Open a free brokerage account and start building your portfolio today.
ISCO
$0.18
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous ...
View full profileConnect your bank account to understand your spending habits and explore hypothetical growth scenarios. For educational purposes only — not investment advice.
Educational illustration: hypothetical DCA into International Stem Cell Corporation (ISCO) over the past year. This is not a recommendation to buy this security.
Total Invested
$1,400
14 months
Worth Today
$1,849
at current price
Profit
+$449
+32.1% return
Hypothetical illustration using historical prices. This is for educational purposes only and is not investment advice. Past performance does not guarantee future results. Nuvestan is not a registered investment adviser. Consult a financial professional before making investment decisions.